Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal typeJean-Marie Michot, Renaud Mazeron, Alina Danu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2008
Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphomaShotaro Nakamura, Hongtao Ye, Chris M Bacon, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 24, 2021
Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)Jean-Baptiste Delhorme, Laurent Villeneuve, Olivier Bouché, et al.American Journal of Hematology|January 23, 2016
Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort studyEmmanuel Bachy, Jane A Estell, Eric Van de Neste, et al.Annales De Pathologie|March 18, 2014
[Peritoneal malignant mesothelioma: review and recent data]Éliane Mery, Juliette Hommell-Fontaine, Mathieu Capovilla, et al.Annales De Pathologie|March 18, 2014
[Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies]Peggy Dartigues, Sylvie Isaac, Laurent Villeneuve, et al.Blood|August 14, 2012
Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphismsHervé Ghesquières, Guillaume Cartron, John Francis Seymour, et al.European Journal of Cancer (Oxford, England : 1990)|November 3, 2023
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trialDavid Malka, Benjamin Verret, Matthieu Faron, et al.Histopathology|July 27, 2017
The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritoneiNorman J Carr, Frederic Bibeau, Robert F Bradley, et al.Annales De Pathologie|March 18, 2014
[The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists]Laurent Villeneuve, Sylvie Isaac, Olivier Glehen, et al.Pageof 8